These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33091816)
1. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis. Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816 [TBL] [Abstract][Full Text] [Related]
2. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment. Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087 [TBL] [Abstract][Full Text] [Related]
3. CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma. Le TN; Le MK; Dang MX; Kondo T Pathol Res Pract; 2024 Sep; 261():155474. PubMed ID: 39067172 [TBL] [Abstract][Full Text] [Related]
4. Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies. Mohanty A; Afkhami M; Reyes A; Pharaon R; Yin H; Li H; Do D; Bell D; Nam A; Chang S; Gernon T; Kang R; Amini A; Sampath S; Kulkarni P; Pillai R; Villaflor V; Salgia R; Maghami E; Massarelli E J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39074963 [TBL] [Abstract][Full Text] [Related]
5. [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration]. Wang Q; Song B; Hao S; Xiao Z; Jin L; Zheng T; Chai F Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):981-988. PubMed ID: 38862457 [TBL] [Abstract][Full Text] [Related]
6. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
7. Analysis of lncRNA-miRNA-mRNA interactions identified a novel biomarker LINC00657 to improve prognosis prediction of papillary thyroid carcinoma. Li S; Wang M; Liu B; Lv Y; Man J; Liang M; Qiao H Int Immunopharmacol; 2024 Aug; 137():112432. PubMed ID: 38865751 [TBL] [Abstract][Full Text] [Related]
8. The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy. Li X; Jian J; Zhang A; Xiang JM; Huang J; Chen Y Sci Rep; 2024 Aug; 14(1):18125. PubMed ID: 39103463 [TBL] [Abstract][Full Text] [Related]
9. TET1 is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Papillary Thyroid Cancer. Zhao YX; Ma LB; Yang Z; Zhang TH; Wang Y; Xiang C Biochem Genet; 2024 Apr; 62(2):718-740. PubMed ID: 37410307 [TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma. Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621 [TBL] [Abstract][Full Text] [Related]
11. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma. Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma. Li M; Fu X; Zhou T; Han H BMC Med Genomics; 2024 Aug; 17(1):199. PubMed ID: 39113023 [TBL] [Abstract][Full Text] [Related]
13. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification. Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057 [TBL] [Abstract][Full Text] [Related]
14. Correlate tumor mutation burden with immune signatures in human cancers. Wang X; Li M BMC Immunol; 2019 Jan; 20(1):4. PubMed ID: 30634925 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing. Zheng K; Zhang XX; Yu X; Yu B; Yang YF Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457 [TBL] [Abstract][Full Text] [Related]
16. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors. Wu P; Sun W; Zhang H Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303 [TBL] [Abstract][Full Text] [Related]
17. Machine learning-based approach for efficient prediction of diagnosis, prognosis and lymph node metastasis of papillary thyroid carcinoma using adhesion signature selection. Sun S; Cai X; Shao J; Zhang G; Liu S; Wang H Math Biosci Eng; 2023 Nov; 20(12):20599-20623. PubMed ID: 38124567 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. Xu Z; Xiang L; Wang R; Xiong Y; Zhou H; Gu H; Wang J; Peng L Biomed Res Int; 2021; 2021():8072796. PubMed ID: 34888385 [TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis. Nam M; Yang W; Kim HS; Park J; Park G; Kim S; Song S; Ock CY; Wang VG; Chuang JH; Chae YK Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279258 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer. Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]